Impact of Targeted Immune Checkpoint Inhibitor Adjuvant Therapy on Recurrence-Free Survival and Functional Recovery in Stage III Tongue Cancer Patients: A Retrospective Cohort Study.

AiRuiKa (camrelizumab) - Elevar Therapeutics

http://www.ncbi.nlm.nih.gov/pubmed/42487911

Chengjie Li; Jing Li; Jingjing Kong; Yanfeng Lou; Yi Shuai; Yuyang Zhou

Jul 24, 2026